Overview
Dr. Paulina Liberman, M.D, is an assistant professor of ophthalmology specializing in ocular immunology at the Wilmer Eye Institute, Johns Hopkins Medicine, located at its East Baltimore and Odenton facilities. Dr. Liberman has focused her clinical practice on the treatment and management of uveitis, employing advanced therapeutic methods to prevent and mitigate vision loss. Her approach combines rigorous clinical care with extensive research aimed at improving treatment protocols for ocular inflammation. Before her appointment at Johns Hopkins, Dr. Liberman directed the uveitis division at the Pontificia Universidad Católica de Chile’s Department of Ophthalmology, where she integrated clinical care with academic initiatives. She has extensive experience in cataract and refractive surgery, in which she aims to achieve optimal visual outcomes through precise surgical techniques and thorough preoperative planning. Her medical expertise also includes using immunosuppressive therapy to manage complex ocular diseases such as ocular pemphigoid, scleritis, peripheral ulcerative keratitis and uveitis. Dr. Liberman's academic contributions include numerous peer-reviewed publications that focus on the diagnostics and treatment of uveitis. She serves as a reviewer for several notable journals in ophthalmology and is an active member of the American Academy of Ophthalmology and the American Uveitis Society.
Her clinical expertise encompasses Uveitis.
Dr. Liberman is currently accepting new patients.
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1106 Annapolis Road, Suite 290, Odenton, MD 21113
Additional Areas of Focus
Dr. Liberman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Brian Brooks is an Ophthalmologist practicing medicine in Washington, Washington, D.c.. Dr. Brooks is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Coloboma, Albinism, Oculocutaneous Albinism Type 1, and Oculocutaneous Albinism.
The Johns Hopkins Hospital
Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy. Dr. Campochiaro is board certified in American Board Of Ophthalmology. Dr. Campochiaro is currently accepting new patients.
Dept Of Transfusion Medicine/Nih Clinical Center
Emily Chew is an Ophthalmologist practicing medicine in Bethesda, Maryland. Dr. Chew is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Von Hippel-Lindau (VHL) Syndrome, and Cataract Removal.
Frequently Asked Questions about Dr. Paulina Liberman
How do I make an appointment with Dr. Paulina Liberman?
You can book an appointment with Dr. Paulina Liberman by calling their office at 410-874-1425. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
What conditions does Dr. Paulina Liberman specialize in?
While Dr. Paulina Liberman is a Ophthalmology, they have specific expertise in Uveitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Ophthalmology.
Does Dr. Paulina Liberman accept my insurance?
Dr. Paulina Liberman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-874-1425 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers